Body Composition Analysis in Patients Undergoing Chemoembolization
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01777698|
Recruitment Status : Completed
First Posted : January 29, 2013
Last Update Posted : June 8, 2016
Hepatocellular carcinoma represents 80-90% of primary hepatic malignant tumors. 80% of patients with hepatocellular carcinoma are associated with cirrhosis.
Chemoembolization is a process in which a chemotherapeutic agent is deposited directly into the hepatic tumor where the principal artery is embolized.
Bioelectrical impedance bases its evaluation in a model where the body is conformed by two different compartments: fat mass and fat free mass.
Bioelectrical impedance is complemented by vectorial analysis, which is independent to the state of hydration and is helpful to monitor any changes in corporal composition. It can be used as a control for the interpretation of the bioelectrical impedance.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||21 participants|
|Official Title:||Body Composition Analysis by Bioelectrical Impedance Vector Analysis in Patients With Hepatocellular Carcinoma Undergoing Chemoembolization.|
|Study Start Date :||April 2012|
|Actual Primary Completion Date :||August 2015|
|Actual Study Completion Date :||March 2016|
- Changes in body composition [ Time Frame: 1 hour before treatment, 2 weeks after treatment, and 1 month after treatment ]To evaluate any changes in corporal composition in patients undergoing chemoembolization.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01777698
|Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"|
|Mexico city, Mexico, 14000|
|Study Chair:||Aldo Torre, M.D, M.Sc.||Instituto Nacional de Nutrición y Ciencias Médicas "Salvador Zubirán"|